alexa Candidate Gene Approaches Reveal New Target Pathways For Treating Antibiotic-resistant Gramnegative Bacterial Infections
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Congress on Bacteriology & Infectious Diseases
November 17-19, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Zachary C Conley
Posters: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.007
Abstract
New antibiotics are needed because resistance has rendered many existing drugs ineffective. We discovered that the antifungal drug, ciclopirox, prevents growth of problematic, multidrug-resistant clinical isolates, although the drug target remains elusive. We showed that both sugar metabolism and free iron in the growth medium affect ciclopirox inhibition of E. coli. Additionally, iron-acquiring siderophore production in P. aeruginosa was increased in the presence of ciclopirox, implying a disruption of iron acquisition. We performed a literature search and identified 103 genes involved in specific ironutilization and sugar metabolism pathways. To test for those that are affected by ciclopirox, we screened gene deletion strains for increased sensitivity to ciclopirox. We filtered out those gene deletions affected by any antibiotic based on the literature. Because ciclopirox can bind free iron, we screened our remaining 29 gene set for increased sensitivity to the iron chelator 1, 10-phenanthroline. This stratification resulted in 18 gene deletions with increased susceptibility to ciclopirox alone. Most of these genes encode proteins involved with the synthesis of the surface glycolipid enterobacterial common antigen, consistent with our laboratory?s published work that shows ciclopirox alters glycolipid expression in the cell outer membrane. Other stratified genes encode proteins involved in the uptake of the siderophore enterobactin. We conclude that ciclopirox interferes in multiple pathways including the construction of glycolipids and iron acquisition. These data are an important step toward developing ciclopirox or new derivatives of ciclopirox, as drugs against multidrug-resistant gram-negative pathogens for which few therapeutic options exist currently.
Biography
Zachary C Conley completed his BS in Cellular and Molecular Biology at Westmont College in Santa Barbara, California. He is currently a PhD candidate studying antibiotic resistance in the laboratory of Dr. Lynn Zechiedrich in the Verna and Marrs McLean Department of Biochemistry and Molecular Biology at Baylor College of Medicine in Houston, Texas.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords